U.S. pharmaceutical stocks declined, with BioNTech (BNTX.O) falling 11%, its biggest intraday drop since March 10, after the company announced the termination of its Phase 2 clinical trial for colorectal cancer. Moderna (MRNA.O) fell 5%, and Merck (M

2026-08-28

U.S. pharmaceutical stocks declined, with BioNTech (BNTX.O) falling 11%, its biggest intraday drop since March 10, after the company announced the termination of its Phase 2 clinical trial for colorectal cancer. Moderna (MRNA.O) fell 5%, and Merck (MRK.N) fell 1.3%.